Cephalalgia : an international journal of headache
-
Randomized Controlled Trial Multicenter Study
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.
This study reports the long-term safety and efficacy of erenumab in chronic migraine patients. ⋯ Sustained efficacy of long-term erenumab treatment in patients with chronic migraine is demonstrated, with safety results consistent with the known safety profile of erenumab and adverse event rates comparable to placebo adverse event rates in the double-blind treatment phase.